Get started
Author

Silvia Pérez‐Silanes

Observed names: Perez-Silanes S., Perez‐Silanes Silvia, Pérez-Silanes, S. (Silvia), Pérez-Silanes, Silvia, S Pérez, S. Perez-Silanes, S. Perez‐Silanes, S. Pérez-Silanes, S. Pérez‐Silanes, SILVIA PÉREZ-SILANES, Silvia Perez, Silvia Perez-Silanes, Silvia Perez‐Silanes, Silvia Pérez-Silanes, Silvia Pérez, Silvia Pérez Silanes, Silvia Pérez-Silanes, Silvia Pérez-silanes
ORCID: 0000-0002-6284-4546
Observed ORCID: 0000-0002-6284-4546
OpenAlex ID: A5047906021
Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues
2007 · Asunción Burguete, Eleni Pontiki, et al. · Bioorganic & Medicinal Chemistry Letters · 147
Novel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action
2011 · Luis Berrade, Bárbara Aisa, et al. · Journal of Medicinal Chemistry · 109
Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates
2008 · Nelilma C. Romeiro, Gabriela Aguirre, et al. · Bioorganic & Medicinal Chemistry · 108
Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides
2008 · Esther Vicente, Silvia Pérez-Silanes, et al. · Bioorganic & Medicinal Chemistry · 108
Synthesis and Biological Evaluation of New Quinoxaline Derivatives as Antioxidant and Anti‐Inflammatory Agents
2011 · Asunción Burguete, Eleni Pontiki, et al. · Chemical Biology & Drug Design · 106
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review
2020 · Iván Beltran-Hortelano, Verónica Alcolea, et al. · European Journal of Medicinal Chemistry · 94
New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
2011 · Enrique Torres, Elsa Moreno, et al. · Bioorganic & Medicinal Chemistry Letters · 81
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents
2010 · Saioa Ancizu, Elsa Moreno, et al. · Bioorganic & Medicinal Chemistry · 77
New 1-Aryl-3-(4-arylpiperazin-1-yl)propane Derivatives, with Dual Action at 5-HT1ASerotonin Receptors and Serotonin Transporter, as a New Class of Antidepressants
2000 · Javier Martínez-Esparza, Ana-M. Oficialdegui, et al. · Journal of Medicinal Chemistry · 74
Challenges in Chagas Disease Drug Discovery: A Review
2016 · Rocio Paucar, Elsa Moreno-Viguri, et al. · Current Medicinal Chemistry · 72
Synthesis and structure–activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents
2008 · Esther Vicente, Lidia M. Lima, et al. · European Journal of Medicinal Chemistry · 68
Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease
2017 · Ivan Beltran-Hortelano, Silvia Perez-Silanes, et al. · Current Medicinal Chemistry · 62
New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities
2011 · Carlos Barea, Adriana Pabón, et al. · Bioorganic & Medicinal Chemistry Letters · 61
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
2017 · Guilherme Felipe dos Santos Fernandes, Paula Carolina de Souza, et al. · Journal of Medicinal Chemistry · 60
Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease
2022 · Iván Beltran-Hortelano, Verónica Alcolea, et al. · Bioorganic & Medicinal Chemistry · 58
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives
2010 · Elsa Moreno, Saioa Ancizu, et al. · European Journal of Medicinal Chemistry · 58
3-Trifluoromethylquinoxaline N,N′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action Studies
2011 · Diego Benitez, Mauricio Cabrera, et al. · Journal of Medicinal Chemistry · 57
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide
2008 · R. Villar, E. Vicente, et al. · Journal of Antimicrobial Chemotherapy · 57
Synthesis and Biological Evaluation of New 2-Arylcarbonyl-3-trifluoromethylquinoxaline 1,4-Di-N-oxide Derivatives and Their Reduced Analogues
2007 · Beatriz Solano, Venkatraman Junnotula, et al. · Journal of Medicinal Chemistry · 57
Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents
2013 · Enrique Torres, Elsa Moreno-Viguri, et al. · European Journal of Medicinal Chemistry · 51
Trypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives
2011 · Yannick Estevez, Miguel Quiliano, et al. · Experimental Parasitology · 50
Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis
2008 · Esther Vicente, Raquel Villar, et al. · Antimicrobial Agents and Chemotherapy · 50
Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs
2009 · Saioa Ancizu, Elsa Moreno, et al. · Molecules · 49
PDF
Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
2008 · Gildardo Rivera, Virgilio Bocanegra-Garcia, et al. · Current Medicinal Chemistry · 48
Synthesis and Molecular Modeling of New 1-Aryl-3-[4-arylpiperazin-1-yl]-1-propane Derivatives with High Affinity at the Serotonin Transporter and at 5-HT1A Receptors
2002 · Lara Orús, Silvia Pérez-Silanes, et al. · Journal of Medicinal Chemistry · 46
Works count: 114
Citation count: 2,771
H-index: 35
I10-index: 62
Year
Topic
Type